PlainPharmaWatch

CMS Open Payments · Program Year 2024

BIOTRONIK NRO, Inc.

BIOTRONIK NRO, Inc. reported $843,137.16 across General Payments, Research, and Ownership to 9,395 physicians and teaching hospitals across 9,399 transactions.

See the rankings → How this is sourced
$843.1K
All-tracks total
9,399
Transactions
9,395
Recipients
+$652.3K
General Payments vs PY2023

BIOTRONIK NRO, Inc. reported $843,137.16 across all CMS Open Payments tracks (General + Research + Ownership) to 9,395 physicians and teaching hospitals in Program Year 2024 - ranking #659 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $814,500.82, averaging $89.74 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer biotronik-nro-inc BIOTRONIK NRO, Inc.

$843.1K · #659/1,925 · 0.0% industry · PY2024

  • TOT $843.1K
  • RANK #659
  • SHARE 0.0%
  • TXN 9,399
  • RCP 9,395
  • CAT 6
  • GEN $814.5K
  • ΔGEN +$652.3K
  • TOP1 3.7%
  • PY 2024

Volume peers

Nearest volume peer: Celltrion USA Inc. ($844.6K)

Histosonics, Inc.$847.9KTrilliant Surgical LLC.$844.6KCelltrion USA Inc.$844.6KBIOTRONIK NRO, Inc. (this)$843.1KProvepharm Inc.$837.3K
All-tracks payment totals near BIOTRONIK NRO, Inc. (CMS Open Payments PY2024)

BIOTRONIK NRO, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

BIOTRONIK NRO, Inc.'s CMS-reported General Payments increased by $652.3K (+402.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: BIOTRONIK NRO, INC.PY2024: BIOTRONIK NRO, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$162.2KPY2024$814.5K
PY2023
$162,171.24
PY2024
$814,500.82

What the Data Shows for BIOTRONIK NRO, Inc.

In Program Year 2024, BIOTRONIK NRO, Inc. reported $843,137.16 in payments to 9,395 physicians and teaching hospitals across 9,399 individual transactions, an average of $89.70 per transaction and $89.74 per recipient. That total places BIOTRONIK NRO, Inc. at rank #659 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $426.0K, accounting for 52.3% of this company's General Payments and 9,099 transactions.

General Payment Breakdown by Type

BIOTRONIK NRO, Inc. made 6 types of general payments. "Food and Beverage" is the largest category at $426.0K, 52.3% of General Payments.

BIOTRONIK NRO, Inc. reports 6 general-payment categories - the top three are Food and Beverage (52.3%), Compensation for Faculty or Speaker (Medical Education) (25.6%), and Consulting Fee (11.6%). The remaining 3 categories make up 10.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How BIOTRONIK NRO, Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$426.0K2. Compensation for Faculty …$208.3K3. Consulting Fee$94.6K4. Travel and Lodging$74.9K5. Grant$10.0K6. Education$632.82
Payment Type Amount Transactions
Food and Beverage $426.0K 9,099
Compensation for Faculty or Speaker (Medical Education) $208.3K 59
Consulting Fee $94.6K 33
Travel and Lodging $74.9K 199
Grant $10.0K 1
Education $632.82 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $134,198.42 (16.5%) of $814,500.82 in this company's General Payments records across 1,767 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for BIOTRONIK NRO, Inc.

The five named recipients with the highest reported General Payments from this company

Leonardo Kapural$30.4KRamana Naidu$29.5KJason Pope$27.8KCaitlin Tourje$26.3KJesse Hatgis$20.2K
  1. 1

    Leonardo Kapural

    $30,390.02 across 32 reported transactions

  2. 2

    Ramana Naidu

    $29,480.36 across 83 reported transactions

  3. 3

    Jason Pope

    $27,802.31 across 36 reported transactions

  4. 4

    Caitlin Tourje

    $26,294.58 across 106 reported transactions

  5. 5

    Jesse Hatgis

    $20,231.15 across 175 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as BIOTRONIK NRO, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about BIOTRONIK NRO, Inc..

New World Medical,inc.

HHI 114

Exact Sciences Corporation

HHI 115

Sobi, Inc

HHI 114

Pyros Pharmaceuticals, Inc.

HHI 114

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with BIOTRONIK NRO, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download BIOTRONIK NRO, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.